Indication
Kidney transplant rejection
Kidney transplant rejection is an immunologic complication occurring in renal allograft recipients where the host immune system identifies donor human leukocyte antigens as foreign and mounts an alloimmune attack. Read more about Kidney transplant rejection
5 drugs 4 manufacturers
Drugs that treat it
Common Kidney transplant rejection therapies.
ORTHOCLONE OKT3 (muromonab-CD3)
THYMOGLOBULIN (anti-thymocyte globulin,rabbit)
ATGAM (lymphocyte immune globulin,antithymocyte (equine))
ATGAM (lymphocyte immune globulin,antithymocyte (equine))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonKidney transplant rejection is an immunologic complication occurring in renal allograft recipients where the host immune system identifies donor human leukocyte antigens as foreign and mounts an alloimmune attack.
It primarily compromises the renal system and allograft vasculature, categorized temporally and mechanistically into hyperacute, acute, or chronic forms driven by T-cell-mediated pathways, donor-specific antibody-mediated injury, or mixed mechanisms.
Clinically, rejection manifests as acute or progressive graft dysfunction characterized by elevated serum creatinine, reduced urine output, proteinuria, and characteristic histopathologic features including tubulitis, interstitial inflammation, or microvascular capillaritis.
- nih.gov
Kidney transplant rejection is an immunologic complication occurring in renal allograft recipients where the host immune system identifies donor human leukocyte antigens as foreign and mounts an alloimmune attack Clinically, rejection manifests as acute or progressive graft dysfunction characterized by elevated serum creatinine, reduced urine output, proteinuria, and characteristic histopathologic features including tubulitis, interstitial inflammation, or microvascular capillaritis
- nih.gov
Kidney transplant rejection is an immunologic complication occurring in renal allograft recipients where the host immune system identifies donor human leukocyte antigens as foreign and mounts an alloimmune attack
- nih.gov
It primarily compromises the renal system and allograft vasculature, categorized temporally and mechanistically into hyperacute, acute, or chronic forms driven by T-cell-mediated pathways, donor-specific antibody-mediated injury, or mixed mechanisms Clinically, rejection manifests as acute or progressive graft dysfunction characterized by elevated serum creatinine, reduced urine output, proteinuria, and characteristic histopathologic features including tubulitis, interstitial inflammation, or mi...
- kidneyfund.org
Clinically, rejection manifests as acute or progressive graft dysfunction characterized by elevated serum creatinine, reduced urine output, proteinuria, and characteristic histopathologic features including tubulitis, interstitial inflammation, or microvascular capillaritis
Personalize your experience
Follow Kidney transplant rejection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.